ALHC: Proposed sale of 90,000 shares

ALHC proposes the sale of 90,000 shares of Common Stock under a Rule 144 notice.

Rhea-AI Filing Summary

ALHC proposes the sale of 90,000 shares of Common Stock under a Rule 144 notice. The filing lists an aggregate value of $1,915,200.00 and reports 204,296,493 shares outstanding as of 04/15/2026. The excerpt also discloses recent 10b5-1 sales by Dawn Maroney totaling multiple transactions in February–March 2026, including 36,749 and 30,000 share sales.

Insights

Securities Compliance Analyst

Form 144 records a proposed insider sale of 90,000 shares and shows executed 10b5-1 transactions.

Form 144 is a regulatory notice of a proposed sale by an affiliate or insider. The filing itemizes the securities to be sold (90,000 shares) and includes an aggregate dollar figure ($1,915,200.00), plus an outstanding share count as of 04/15/2026.

Several past sales by Dawn Maroney are listed as 10b5-1 plan trades in Feb–Mar 2026, indicating prearranged dispositions. Timing and method of the proposed 90,000-share sale are not specified in the excerpt.

Key Figures

Proposed shares to be sold: 90,000 shares Aggregate value listed: $1,915,200.00 Shares outstanding: 204,296,493 shares +2 more

5 metrics

Proposed shares to be sold 90,000 shares listed on Form 144 cover data

Aggregate value listed $1,915,200.00 cover data associated with the 90,000 shares

Shares outstanding 204,296,493 shares as of 04/15/2026

Recent 10b5-1 sale example 36,749 shares sale on 03/18/2026 for $655,602.16 by Dawn Maroney

Recent 10b5-1 sale example 30,000 shares sale on 03/16/2026 for $524,426.00 by Dawn Maroney

Key Terms

Form 144, 10b5-1, RSU/PSU

3 terms

Form 144 regulatory

"144: Filer Information | 144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for DAWN MARONEY ... 03/18/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

RSU/PSU financial

"Common | 09/30/2019 | RSU/PSU | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ALHC's Form 144 mean for shareholders?

It notifies the SEC of a proposed insider sale of 90,000 shares. The filing lists an aggregate value of $1,915,200.00 and provides recent selling activity by the reporting person.

Who completed recent sales shown in the ALHC excerpt?

The excerpt lists multiple sales by Dawn Maroney in Feb–Mar 2026. Transactions include 36,749 and 30,000 share sales executed under 10b5-1 trading plans, per the filing text.

How many ALHC shares are reported outstanding in this filing?

The filing states 204,296,493 shares outstanding as of 04/15/2026. That figure appears on the Form 144 cover data in the provided excerpt.

Does the filing say when the 90,000 shares will be sold?

The excerpt lists the 90,000 shares proposed for sale but does not state the specific sale timing or distribution method for that proposed amount in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:54 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001850397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE, INC.
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	DAWN MARONEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	90000	1915200.00	204296493	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2019	RSU/PSU	Issuer			90000	09/30/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	03/18/2026	36749	655602.16
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	03/16/2026	30000	524426.00
DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	03/12/2026	29113	507925.32
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	02/17/2026	30000	618989.50

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units and performance stock units during the period of 09/30/2019 through 03/25/2025.
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/22/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dawn Maroney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)